Novel therapies for malignant pleural effusion: Anti‑angiogenic therapy and immunotherapy (Review)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel therapies for malignant pleural effusion: Anti‑angiogenic therapy and immunotherapy (Review)

Published:2021-01-22 Issue:3 Volume:58 Page:359-370
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

He Dan¹,Ding Ruilin²,Wen Qinglian³,Chen Longxia²

Affiliation:

1. College of Medical Technology, Sichuan College of Traditional Chinese Medicine, Mianyang, Sichuan 621000, P.R. China

2. Institute of Drug Clinical Trial/GCP Center, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China

3. Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intra-pleural and intra-peritoneal tocilizumab therapy for managing malignant pleural effusions and ascites: The Regional Immuno-Oncology Trial (RIOT)−2 study protocol;Surgical Oncology Insight;2024-06

2. Case report: Envafolimab combined with Endostar in the treatment of advanced non-small cell lung cancer with malignant pleural effusion;Frontiers in Oncology;2024-04-04

3. Engineered lactococcus lactis intrapleural therapy promotes regression of malignant pleural effusion by enhancing antitumor immunity;Cancer Letters;2024-04

4. Development of machine learning-based malignant pericardial effusion-related model in breast cancer: Implications for clinical significance, tumor immune and drug-therapy;Heliyon;2024-03

5. Development and validation of the CAIL prognostic score in non‐small cell lung cancer patients with malignant pleural effusion;The Clinical Respiratory Journal;2023-09-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3